MicrobiologyNature CommunicationsPeer-reviewed
Genome-wide antibiotic-CRISPRi profiling identifies LiaR activation as a strategy to resensitize fluoroquinolone-resistant Streptococcus pneumoniae
Bevika Sewgoolam, Kin Ki Jim, Vincent de Bakker…·Jan‐Willem Veening
The paper identifies LiaR activation as a strategy to resensitize fluoroquinolone-resistant Streptococcus pneumoniae using CRISPRi-seq and antibiotic combination therapy.
13 citationstop 2%